PAVE syndrome could be fatal

Article

Presumed Air by Vitrectomy Embolisation (PAVE) could be a fatal syndrome, states a paper in the British Journal of Ophthalmology.

Presumed Air by Vitrectomy Embolisation (PAVE) could be a fatal syndrome, states a paper in the British Journal of Ophthalmology.

A study led by Dr Robert E. Morris, Helen Keller Foundation for Research and Education, Birmingham, Alabama, USA, included the analysis of three cases of suspected venous air embolism (VAE). The team investigated how air exits the eye through vortex veins after accidental suprachoroidal air infusion.

The group performed vitrectomy on four donor eyes. During air fluid exchange the unsutured cannulas were partially withdrawn and this produced choroidal detachments that imitated accidental suprachoroidal air infusion from a slipping cannula. A water bath was used to partially submerge eyes with and without clamping of the vortex vein stumps.

According to the findings, extensive choroidal detachment was created in all eyes and all patients with open vortex veins demonstrated rapid air extravasation/bubbling.

The results of the experiment support the recognition of PAVE and demonstrate that simple surgical precautions can prevent the potentially fatal vitrectomy complication.

Please click here to read the abstract.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Omer Trivizki, MD, MBA, a retina specialist from Tel Aviv Medical Center, speaks about VOY-101, a Novel, Complement-Modulating Gene Therapy for Geographic Atrophy at the American Society of Retina Specialists (ASRS) Annual Meeting
João Pedro Marques, MD, MSc, PhD discusses a retrospective study of 800 patients with inherited retinal diseases during the American Society of Retina Specialists (ASRS) annual meeting
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
© 2025 MJH Life Sciences

All rights reserved.